Dubai: As the COVID-19 pandemic adds a new size to medical diplomacy in India and the UAE, high-level diplomats, fitness officials and fitness giants have committed to bilateral cooperation in the medical field.
The message was conveyed loud and transparent at the “United Arab Emirates-India 2020 Health Conference” held on Monday.
“In the wake of the COVID-19 pandemic, there is a new size of international medical relations between the United Arab Emirates and India,” said UAE Ambassador to India Dr. Ahmed Al Banna.
“We imported medicines from India and were able to download a special permit to import hydroxychloroquine and for the workers’ medical corps to come to the UAE to our existing health care platform,” he said.
“While the Indian government helped and facilitated through the Embassy and Consulate for the repatriation of Indians, we worked very intensively with the Indian Ministry of Foreign Affairs for the repatriation of citizens of the United Arab Emirates in April. “
Although the two countries enjoy a comprehensive strategic relationship, Al Banna noted that there is still great untapped potential in health, medicine and similar sectors where countries can collaborate more.
Echoing the same thing, India’s ambassador to the United Arab Emirates, Pavan Kapoor, said the UAE had expressed its preference for establishing vaccine and generic production services through Indian corporations with studies and progression services.
“The government of the United Arab Emirates will generate incentives, adding monetary contributions, and will also try to create a comprehensive ecosystem to help health care production corporations in India,” he said, urging Indian corporations to take a look at the supply, which they will provide with a fair opportunity. GCC, as well as African markets, the pharmaceutical chain ecosystem.
Policymakers, fitness officers and leading fitness leaders and similar sectors in the two countries exchanged concepts on exploring new avenues of partnership at the virtual conference.
Humaid Al Qutami, Director General of the Dubai Health Authority, highlighted spaces such as innovation, studies and development, medical education and training and telehealth, where there is a perspective of collaboration.
Abdulla Ali Al Mahyan, president of the Sharjah Health Authority, and Dr. Amin Hussain Al Amiri, Deputy Under-Secretary of Health And Licensing Policies at the UAE Ministry of Health and Prevention, highlighted the old and strategic dating between the two countries.
El Dr. Al Amiri said a large number of medical professionals in the United Arab Emirates are from India. “Thirty% of fitness professionals in our public sector and 42% of them in the personal sector are from India. “
In addition to human energy, he said that more than 10% of the medicinal plants that the UAE treated internationally are in India.
“There are 2,300 production plants that have registered with us and 256 of them are in India. “
Nearly 10,000 medical products registered in the United Arab Emirates come from India. Al Amiri said 10% of traditional drugs, 26% of naturally used drugs and 6% of biological and biosimilar drugs in the United Arab Emirates came from India.
Most factories in the United Arab Emirates also have raw Indian fabrics to produce 1,600 medicines, he said.
“We have cooperation with India. Therefore, the possibilities are greater, the opportunities are there and we look to the future to help any Indian pharmaceutical or medical industry invest with us,” he added.
Dr. Abdul Salam Al Madani, executive chairman of the Waterfalls initiative in the United Arab Emirates to exercise one million fitness professionals worldwide, said the country hoped to race with Indian fitness professionals to enroll in the initiative as sneakers and athletes. there was a desire to expand the industry’s relations with India.
Dr. Sangita Reddy, president of the Federation of Indian Chambers of Commerce and Industry (FICCI) and Deputy Managing Director of Apollo Hospitals Group, said: “As the world fights COVID, now is the right time for us to move from a convention to collaborations in the field of medicine.
He also put forward a proposal for accredited fitness professionals in India to be recognized in the UAE.
India’s consul general in Dubai, Dr. Aman Puri, said the convention was even more applicable as key stakeholders in the fitness landscapes of the United Arab Emirates met to plan the exploration of new avenues of partnership between the two countries.
Dr. Praveen Gedam, additional executive director of the National Health Authority of India; Dr. Azad Moopen, President and CEO of Aster DM Healthcare; Dr. Shamsheer Vayalil, President and CEO, VPS Healthcare Group, Girish Krishnamurty, CEO and Director of Tata Medical and Diagnostics, Dr. Akbar Moideen, Vice President, Thumbay Group; Dr. Viren Shetty of Narayana Hrudayalaya; Sophiya Faizal, director of KEF Holdings (Meitra Hospital) and Dr. Taher Shams, MD Zulekha India, provided on physical care opportunities in the United Arab Emirates and India.
Meanwhile, a cheap COVID-19 paper check recently passed through the Indian government highlighted through a high-ranking Tatar from the Tata Group, who developed the check.
Speaking at the conference, Girish Krishnamurthy, ceo of Tata Medical and Diagnostics (Tata MD), said the company had won “several interests of the United Arab Emirates” for “Feluda”, the Tata CRISPR (short palindromic repetitions grouped regularly interspaced) COVID -19 test.
Feluda, an acronym for FNCAS9 Editor-Limited Uniform Detection Assay, is also named after the celebrated fictional Bengali detective who gave the impression in the novels of acclaimed director and screenwriter Satyajit Ray.
The verification approach will change the rules of the game in the verification of pandemic diseases by replacing the expensive and slow RT-PCR (chain reaction through the opposite transcription polymer) which is lately considered the popular gold of COVID-19 controls, Krishnamurthy said. .
“Many laboratories and hospitals are in verbal exchange with us, not just India, around the world. We have interests in the United Arab Emirates,” he said.
The Indian approved the release of Feluda’s announcement on September 20.
CRISPR is a genome editing generation for disease diagnosis. Tata CRISPR would have achieved the precision grades of classic RT-PCRs with shorter response times, less expensive appliances and improved usability.
Krishnamurthy said verification is simple, reliable and highly scalable. Rt-PCR requires an expensive device that is not mandatory in the case of Feluda, he said.
“The response time is very fast. In forty-five minutes, you can perform viral control, nucleic acid control, and, more importantly, get an inviolable result. We have an audit trail of the result through a strip of paper. “
Krishnamurthy said the company had set up a giant factory to produce a giant volume of kits in order to meet needs in India and around the world.
“All product tested on several thousand genuine samples in India prior to Indian government approval. “
He said corporate lately in a primary production mode.
“We’re going to bring this to the global until the end of this month. From that moment on, we will start to generate a significant volume for the global . . . In the next two or 3 months, I think we will be able to manage india’s call and global call.
In reaction to a Gulf News consultation on Feluda’s source to the UAE market, the Indian Consulate in Dubai said the company would record mandatory approvals for the source of verification kits to countries, adding the United Arab Emirates.
“It will be introduced internationally once approvals have been obtained,” the project said.
Dear reader,
This segment is about life in the United Arab Emirates and data without which you cannot live.
Sign up to read and complete gulfnews. com